Literature DB >> 35420690

TP53 and the star-crossed lovers MDS and AML.

John S Welch1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35420690      PMCID： PMC9012128          DOI： 10.1182/blood.2022015709

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  10 in total

1.  Clonal architecture of secondary acute myeloid leukemia.

Authors:  Matthew J Walter; Dong Shen; Li Ding; Jin Shao; Daniel C Koboldt; Ken Chen; David E Larson; Michael D McLellan; David Dooling; Rachel Abbott; Robert Fulton; Vincent Magrini; Heather Schmidt; Joelle Kalicki-Veizer; Michelle O'Laughlin; Xian Fan; Marcus Grillot; Sarah Witowski; Sharon Heath; John L Frater; William Eades; Michael Tomasson; Peter Westervelt; John F DiPersio; Daniel C Link; Elaine R Mardis; Timothy J Ley; Richard K Wilson; Timothy A Graubert
Journal:  N Engl J Med       Date:  2012-03-14       Impact factor: 91.245

2.  Does a diagnosis of myelogenous leukemia require 20% marrow myeloblasts, and does <5% marrow myeloblasts represent a remission? The history and ambiguity of arbitrary diagnostic boundaries in the understanding of myelodysplasia.

Authors:  Marshall A Lichtman
Journal:  Oncologist       Date:  2013-08-27

3.  Characterization of chronic myelomonocytic leukemia with TP53 mutations.

Authors:  Wei Wang; Mark J Routbort; Sanam Loghavi; Zhenya Tang; L Jeffrey Medeiros; Sa A Wang
Journal:  Leuk Res       Date:  2018-05-31       Impact factor: 3.156

Review 4.  MDS overlap disorders and diagnostic boundaries.

Authors:  Tiffany N Tanaka; Rafael Bejar
Journal:  Blood       Date:  2019-01-22       Impact factor: 22.113

5.  Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers.

Authors:  Kiran Naqvi; Elias Jabbour; Carlos Bueso-Ramos; Sherry Pierce; Gautam Borthakur; Zeev Estrov; Farhad Ravandi; Stefan Faderl; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Blood       Date:  2011-08-25       Impact factor: 22.113

Review 6.  Clonal hematopoiesis: Pre-cancer PLUS.

Authors:  Alexander J Silver; Siddhartha Jaiswal
Journal:  Adv Cancer Res       Date:  2019-01-14       Impact factor: 6.242

7.  Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.

Authors:  Pontus Lundberg; Axel Karow; Ronny Nienhold; Renate Looser; Hui Hao-Shen; Ina Nissen; Sabine Girsberger; Thomas Lehmann; Jakob Passweg; Martin Stern; Christian Beisel; Robert Kralovics; Radek C Skoda
Journal:  Blood       Date:  2014-01-29       Impact factor: 22.113

8.  Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.

Authors:  Tim Grob; Adil S A Al Hinai; Mathijs A Sanders; François G Kavelaars; Melissa Rijken; Patrycja L Gradowska; Bart J Biemond; Dimitri A Breems; Johan Maertens; Marinus van Marwijk Kooy; Thomas Pabst; Okke de Weerdt; Gert J Ossenkoppele; Arjan A van de Loosdrecht; Gerwin A Huls; Jan J Cornelissen; H Berna Beverloo; Bob Löwenberg; Mojca Jongen-Lavrencic; Peter J M Valk
Journal:  Blood       Date:  2022-04-14       Impact factor: 22.113

9.  Functional Classification of TP53 Mutations in Acute Myeloid Leukemia.

Authors:  Sayantanee Dutta; Gudrun Pregartner; Frank G Rücker; Ellen Heitzer; Armin Zebisch; Lars Bullinger; Andrea Berghold; Konstanze Döhner; Heinz Sill
Journal:  Cancers (Basel)       Date:  2020-03-10       Impact factor: 6.639

10.  TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.

Authors:  H-A Hou; W-C Chou; Y-Y Kuo; C-Y Liu; L-I Lin; M-H Tseng; Y-C Chiang; M-C Liu; C-W Liu; J-L Tang; M Yao; C-C Li; S-Y Huang; B-S Ko; S-C Hsu; C-Y Chen; C-T Lin; S-J Wu; W Tsay; Y-C Chen; H-F Tien
Journal:  Blood Cancer J       Date:  2015-07-31       Impact factor: 11.037
  10 in total
  1 in total

Review 1.  The International Consensus Classification of acute myeloid leukemia.

Authors:  Olga K Weinberg; Anna Porwit; Attilio Orazi; Robert P Hasserjian; Kathryn Foucar; Eric J Duncavage; Daniel A Arber
Journal:  Virchows Arch       Date:  2022-10-20       Impact factor: 4.535
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.